Korro Bio Inc.

NASDAQ: KRRO · Real-Time Price · USD
20.27
0.39 (1.96%)
At close: Aug 15, 2025, 3:59 PM
20.66
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

Korro Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.28M 4.82M 2.27M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.42M 14.07M 24.02M 35.27M 34.37M
Cost of Revenue
865K 1.59M 2.31M 4.06M 4.22M 4.63M 5.53M 5.06M 5.22M 5.45M 5.14M 5.17M 4.79M 3.44M 6.77M 15.41M 25.85M 34.37M
Gross Profit
4.22M 3.23M -41K -4.06M -4.22M -4.63M -5.53M -5.06M -5.22M -5.45M -5.14M -5.17M -4.79M 5.98M 7.3M 8.61M 9.42M n/a
Operating Income
-98.55M -95.48M -91.91M -108.4M -97.77M -85.12M -80.2M -58.87M -66.48M -76.28M -83M -86.17M -90.88M -87.09M -84.03M -72.95M -53.38M -42.09M
Interest Income
n/a n/a n/a n/a 448K 794K 1.32M 1.77M 1.68M 1.33M 807K 433K 254K 372K 397K 347K 249K 309K
Pretax Income
-91.26M -87.29M -83.44M -101.56M -92.17M -81.17M -81.14M -59.29M -67.23M -77.73M -81.58M -85.72M -91.31M -87.67M -84.67M -73.43M -53.6M -41.98M
Net Income
-91.36M -87.41M -83.58M -101.6M -92.22M -81.19M -81.17M -59.31M -67.25M -77.74M -81.58M -85.72M -91.33M -87.7M -84.69M -73.42M -53.6M -41.97M
Selling & General & Admin
31.14M 30.5M 30.55M 22.98M 24.86M 24.05M 22.88M 28.75M 27.32M 28.18M 30.07M 31.16M 32.36M 34.17M 34.93M 35.31M 32.66M 29.58M
Research & Development
73.7M 69.8M 63.64M 83.66M 70.14M 57.16M 51.79M 25.07M 33.95M 42.66M 47.8M 49.84M 53.73M 57.84M 59.32M 58.56M 53.3M 44.93M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
104.83M 100.3M 94.18M 106.65M 95M 81.22M 74.67M 53.81M 61.27M 70.84M 77.87M 81M 86.09M 92.02M 94.26M 93.87M 85.96M 74.51M
Interest Expense
n/a n/a n/a n/a n/a n/a 284K 596K 859K 859K 575K 445K 364K 546K 764K 582K 400K 218K
Selling & Marketing Expenses
n/a n/a 3.8M 4.58M 13.78M 19.95M 22.86M 28.73M 27.3M 22.49M 20.33M 13.68M 5.91M 4.54M n/a n/a n/a n/a
Cost & Expenses
104.83M 100.3M 94.18M 108.4M 97.77M 85.12M 80.2M 58.87M 66.48M 76.28M 83M 86.17M 90.88M 96.51M 98.1M 96.97M 88.64M 76.47M
Income Tax Expense
93K 124K 141K 43K 45K 20K 27K 29K 13K 10K -2K -7K 19K 27K 15K -12K n/a -3K
Shares Outstanding (Basic)
9.39M 9.38M 8.92M 9.3M 8.99M 8.02M 8.02M 5.72M 5.56M 5.46M 5.4M 5.23M 699.53K 696.21K 691.92K 688.97K 684.77K 682.31K
Shares Outstanding (Diluted)
9.39M 9.38M 8.92M 9.3M 8.99M 8.02M 8.02M 5.72M 5.56M 5.46M 5.4M 5.23M 699.53K 696.21K 691.92K 688.97K 684.77K 682.31K
EPS (Basic)
-9.75 -9.44 -9.39 -12.02 -11.79 -11.3 -12.44 -10.76 -12.47 -40.96 -70.97 -98.83 -131.6 -126.95 -123.22 -107.28 -78.84 -62.76
EPS (Diluted)
-9.75 -9.44 -9.39 -12.02 -11.79 -11.3 -12.44 -10.76 -12.47 -40.96 -70.97 -98.83 -131.6 -126.95 -123.22 -107.28 -78.84 -62.76
EBITDA
-95.21M -91.41M -88.34M -102.99M -98.13M -92.22M -90.77M -70.11M -70.66M -72.89M -75.48M -79.73M -85.76M -82.45M -80.07M -69.75M -50.52M -39.8M
EBIT
-97.12M -95.48M -91.91M -107.05M -102.25M -96.53M -95.17M -74.03M -74.84M -77.51M -80.62M -84.89M -90.56M -86.95M -83.91M -72.85M -53.2M -41.76M
Depreciation & Amortization
4.54M 4.06M 3.56M 4.06M 4.12M 4.52M 5.43M 4.96M 5.22M 5.45M 5.14M 5.17M 4.79M 4.49M 3.84M 3.1M 2.68M 1.96M